Cargando…

Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China

BACKGROUND: Autoimmune liver disease (AILD) has been considered a relatively uncommon disease in China, epidemiological data for AILD in patients with cirrhosis and acute decompensation (AD) is sparse. AIM: To investigate the prevalence, outcome and risk factors for AILD in cirrhotic patients compli...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Zi-Xuan, Wu, Dan-Dan, Xia, Jie, Wang, Xian-Bo, Zheng, Xin, Huang, Yan, Li, Bei-Ling, Meng, Zhong-Ji, Gao, Yan-Hang, Qian, Zhi-Ping, Liu, Feng, Lu, Xiao-Bo, Shang, Jia, Yan, Hua-Dong, Zheng, Yu-Bao, Gu, Wen-Yi, Zhang, Yan, Wei, Jian-Yi, Tan, Wen-Ting, Hou, Yi-Xin, Zhang, Qun, Xiong, Yan, Zou, Cong-Cong, Chen, Jun, Huang, Ze-Bing, Jiang, Xiu-Hua, Luo, Sen, Chen, Yuan-Yuan, Gao, Na, Liu, Chun-Yan, Yuan, Wei, Mei, Xue, Li, Jing, Li, Tao, Zhou, Xin-Yi, Deng, Guo-Hong, Chen, Jin-Jun, Ma, Xiong, Li, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453760/
https://www.ncbi.nlm.nih.gov/pubmed/36159019
http://dx.doi.org/10.3748/wjg.v28.i31.4417
_version_ 1784785210369376256
author Shen, Zi-Xuan
Wu, Dan-Dan
Xia, Jie
Wang, Xian-Bo
Zheng, Xin
Huang, Yan
Li, Bei-Ling
Meng, Zhong-Ji
Gao, Yan-Hang
Qian, Zhi-Ping
Liu, Feng
Lu, Xiao-Bo
Shang, Jia
Yan, Hua-Dong
Zheng, Yu-Bao
Gu, Wen-Yi
Zhang, Yan
Wei, Jian-Yi
Tan, Wen-Ting
Hou, Yi-Xin
Zhang, Qun
Xiong, Yan
Zou, Cong-Cong
Chen, Jun
Huang, Ze-Bing
Jiang, Xiu-Hua
Luo, Sen
Chen, Yuan-Yuan
Gao, Na
Liu, Chun-Yan
Yuan, Wei
Mei, Xue
Li, Jing
Li, Tao
Zhou, Xin-Yi
Deng, Guo-Hong
Chen, Jin-Jun
Ma, Xiong
Li, Hai
author_facet Shen, Zi-Xuan
Wu, Dan-Dan
Xia, Jie
Wang, Xian-Bo
Zheng, Xin
Huang, Yan
Li, Bei-Ling
Meng, Zhong-Ji
Gao, Yan-Hang
Qian, Zhi-Ping
Liu, Feng
Lu, Xiao-Bo
Shang, Jia
Yan, Hua-Dong
Zheng, Yu-Bao
Gu, Wen-Yi
Zhang, Yan
Wei, Jian-Yi
Tan, Wen-Ting
Hou, Yi-Xin
Zhang, Qun
Xiong, Yan
Zou, Cong-Cong
Chen, Jun
Huang, Ze-Bing
Jiang, Xiu-Hua
Luo, Sen
Chen, Yuan-Yuan
Gao, Na
Liu, Chun-Yan
Yuan, Wei
Mei, Xue
Li, Jing
Li, Tao
Zhou, Xin-Yi
Deng, Guo-Hong
Chen, Jin-Jun
Ma, Xiong
Li, Hai
author_sort Shen, Zi-Xuan
collection PubMed
description BACKGROUND: Autoimmune liver disease (AILD) has been considered a relatively uncommon disease in China, epidemiological data for AILD in patients with cirrhosis and acute decompensation (AD) is sparse. AIM: To investigate the prevalence, outcome and risk factors for AILD in cirrhotic patients complicated with AD in China. METHODS: We collected data from patients with cirrhosis and AD from two prospective, multicenter cohorts in hepatitis B virus endemic areas. Patients were regularly followed up at the end of 28-d, 90-d and 365-d, or until death or liver transplantation (LT). The primary outcome in this study was 90-d LT-free mortality. Acute-on-chronic liver failure (ACLF) was assessed on admission and during 28-d hospitalization, according to the diagnostic criteria of the European Association for the Study of the Liver (EASL). Risk factors for death were analyzed with logistic regression model. RESULTS: In patients with cirrhosis and AD, the overall prevalence of AILD was 9.3% (242/2597). Prevalence of ACLF was significantly lower in AILD cases (14%) than those with all etiology groups with cirrhosis and AD (22.8%) (P < 0.001). Among 242 enrolled AILD patients, the prevalence rates of primary biliary cirrhosis (PBC), autoimmune hepatitis (AIH) and PBC-AIH overlap syndrome (PBC/AIH) were 50.8%, 28.5% and 12.0%, respectively. In ACLF patients, the proportions of PBC, AIH and PBC/AIH were 41.2%, 29.4% and 20.6%. 28-d and 90-d mortality were 43.8% and 80.0% in AILD-related ACLF. The etiology of AILD had no significant impact on 28-d, 90-d or 365-d LT-free mortality in patients with cirrhosis and AD in both univariate and multivariate analysis. Total bilirubin (TB), hepatic encephalopathy (HE) and blood urea nitrogen (BUN) were independent risk factors for 90-d LT-free mortality in multivariate analysis. The development of ACLF during hospitalization only independently correlated to TB and international normalized ratio. CONCLUSION: AILD was not rare in hospitalized patients with cirrhosis and AD in China, among which PBC was the most common etiology. 90-d LT-free mortality were independently associated with TB, HE and BUN.
format Online
Article
Text
id pubmed-9453760
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-94537602022-09-23 Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China Shen, Zi-Xuan Wu, Dan-Dan Xia, Jie Wang, Xian-Bo Zheng, Xin Huang, Yan Li, Bei-Ling Meng, Zhong-Ji Gao, Yan-Hang Qian, Zhi-Ping Liu, Feng Lu, Xiao-Bo Shang, Jia Yan, Hua-Dong Zheng, Yu-Bao Gu, Wen-Yi Zhang, Yan Wei, Jian-Yi Tan, Wen-Ting Hou, Yi-Xin Zhang, Qun Xiong, Yan Zou, Cong-Cong Chen, Jun Huang, Ze-Bing Jiang, Xiu-Hua Luo, Sen Chen, Yuan-Yuan Gao, Na Liu, Chun-Yan Yuan, Wei Mei, Xue Li, Jing Li, Tao Zhou, Xin-Yi Deng, Guo-Hong Chen, Jin-Jun Ma, Xiong Li, Hai World J Gastroenterol Observational Study BACKGROUND: Autoimmune liver disease (AILD) has been considered a relatively uncommon disease in China, epidemiological data for AILD in patients with cirrhosis and acute decompensation (AD) is sparse. AIM: To investigate the prevalence, outcome and risk factors for AILD in cirrhotic patients complicated with AD in China. METHODS: We collected data from patients with cirrhosis and AD from two prospective, multicenter cohorts in hepatitis B virus endemic areas. Patients were regularly followed up at the end of 28-d, 90-d and 365-d, or until death or liver transplantation (LT). The primary outcome in this study was 90-d LT-free mortality. Acute-on-chronic liver failure (ACLF) was assessed on admission and during 28-d hospitalization, according to the diagnostic criteria of the European Association for the Study of the Liver (EASL). Risk factors for death were analyzed with logistic regression model. RESULTS: In patients with cirrhosis and AD, the overall prevalence of AILD was 9.3% (242/2597). Prevalence of ACLF was significantly lower in AILD cases (14%) than those with all etiology groups with cirrhosis and AD (22.8%) (P < 0.001). Among 242 enrolled AILD patients, the prevalence rates of primary biliary cirrhosis (PBC), autoimmune hepatitis (AIH) and PBC-AIH overlap syndrome (PBC/AIH) were 50.8%, 28.5% and 12.0%, respectively. In ACLF patients, the proportions of PBC, AIH and PBC/AIH were 41.2%, 29.4% and 20.6%. 28-d and 90-d mortality were 43.8% and 80.0% in AILD-related ACLF. The etiology of AILD had no significant impact on 28-d, 90-d or 365-d LT-free mortality in patients with cirrhosis and AD in both univariate and multivariate analysis. Total bilirubin (TB), hepatic encephalopathy (HE) and blood urea nitrogen (BUN) were independent risk factors for 90-d LT-free mortality in multivariate analysis. The development of ACLF during hospitalization only independently correlated to TB and international normalized ratio. CONCLUSION: AILD was not rare in hospitalized patients with cirrhosis and AD in China, among which PBC was the most common etiology. 90-d LT-free mortality were independently associated with TB, HE and BUN. Baishideng Publishing Group Inc 2022-08-21 2022-08-21 /pmc/articles/PMC9453760/ /pubmed/36159019 http://dx.doi.org/10.3748/wjg.v28.i31.4417 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Observational Study
Shen, Zi-Xuan
Wu, Dan-Dan
Xia, Jie
Wang, Xian-Bo
Zheng, Xin
Huang, Yan
Li, Bei-Ling
Meng, Zhong-Ji
Gao, Yan-Hang
Qian, Zhi-Ping
Liu, Feng
Lu, Xiao-Bo
Shang, Jia
Yan, Hua-Dong
Zheng, Yu-Bao
Gu, Wen-Yi
Zhang, Yan
Wei, Jian-Yi
Tan, Wen-Ting
Hou, Yi-Xin
Zhang, Qun
Xiong, Yan
Zou, Cong-Cong
Chen, Jun
Huang, Ze-Bing
Jiang, Xiu-Hua
Luo, Sen
Chen, Yuan-Yuan
Gao, Na
Liu, Chun-Yan
Yuan, Wei
Mei, Xue
Li, Jing
Li, Tao
Zhou, Xin-Yi
Deng, Guo-Hong
Chen, Jin-Jun
Ma, Xiong
Li, Hai
Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China
title Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China
title_full Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China
title_fullStr Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China
title_full_unstemmed Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China
title_short Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China
title_sort prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in china
topic Observational Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453760/
https://www.ncbi.nlm.nih.gov/pubmed/36159019
http://dx.doi.org/10.3748/wjg.v28.i31.4417
work_keys_str_mv AT shenzixuan prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT wudandan prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT xiajie prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT wangxianbo prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT zhengxin prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT huangyan prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT libeiling prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT mengzhongji prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT gaoyanhang prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT qianzhiping prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT liufeng prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT luxiaobo prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT shangjia prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT yanhuadong prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT zhengyubao prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT guwenyi prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT zhangyan prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT weijianyi prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT tanwenting prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT houyixin prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT zhangqun prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT xiongyan prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT zoucongcong prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT chenjun prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT huangzebing prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT jiangxiuhua prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT luosen prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT chenyuanyuan prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT gaona prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT liuchunyan prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT yuanwei prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT meixue prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT lijing prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT litao prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT zhouxinyi prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT dengguohong prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT chenjinjun prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT maxiong prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina
AT lihai prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina